The Journal of clinical psychiatry
-
Randomized Controlled Trial Multicenter Study
A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder.
This study evaluated the efficacy and safety of desvenlafaxine succinate extended-release in major depressive disorder (MDD). ⋯ Desvenlafaxine is effective and well tolerated in the short-term treatment of MDD.